Home / Insights

Insights

Man in lab coat and safety glasses reviews notes
Expert insight Aug 17, 2026

Future advances in vector manufacturing at scale 

Read the blog
Expert insight Dec 10, 2025

De-risking gene therapies on the path to commercialization: 5 insights shaping 2026

Read the blog
Expert insight Aug 27, 2024

Reexamining process optimization: Advanced analytics for AAV manufacturing

Read the blog

More news

Testimonials Aug 03, 2026
Advancing AAV gene therapy together: Continuing our collaboration with Mirugen
Update Jul 28, 2026
DINAMIQS welcomes new leadership team member
Media release Apr 29, 2026
DINAMIQS receives Swissmedic license for viral vector manufacturing and testing
Update Jan 28, 2026
DINAMIQS welcomes new leadership team member
Media release Dec 11, 2025
DINAMIQS obtains ExcellGene’s HEKExpress® and HEK2Express® cell line technologies for viral vector GMP manufacturing
Update Sep 29, 2025
Inside DINAMIQS’ new cGMP facility
Media release Sep 29, 2025
DINAMIQS opens cGMP manufacturing facility for viral vectors
Update May 01, 2025
DINAMIQS welcomes new leadership team member
Update Apr 01, 2025
DINAMIQS welcomes new leadership team member
To top